You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EphA2

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Solid Tumor, Metastatic EphA2 Positive Cancer Trial in Heidelberg (DS-8895a 1 mg/kg, DS-8895a 3 mg/kg, DS-8895a 10

Completed
Has Results
  • Malignant Solid Tumor
  • Metastatic EphA2 Positive Cancer
  • DS-8895a 1 mg/kg
  • +2 more
  • Heidelberg, Victoria, Australia
    Austin Health
Oct 3, 2022

Solid Tumor, Adult, EphA2 Overexpression, KRAS G12V Trial in Beijing (KRAS-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • KRAS-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer Trial in Worldwide (BT5528,

Recruiting
  • Advanced Solid Tumor Historically Known for High EphA2 Expression
  • +6 more
  • Encinitas, California
  • +27 more
Aug 17, 2022

EphA2 Positive Malignant Glioma, CAR-T Cell Immunotherapy Trial in Guangzhou (CAR-T cell immunotherapy)

Withdrawn
  • EphA2 Positive Malignant Glioma
  • CAR-T Cell Immunotherapy
  • CAR-T cell immunotherapy
  • Guangzhou, Guangdong, China
    Central laboratory in Fuda cancer hospital
Jul 14, 2020

Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

Not yet recruiting
  • Glioma, Malignant
  • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
  • Hiltonol
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Jan 19, 2023

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Glioma, Malignant Glioma of Brain, Recurrence Tumor Trial in Beijing (chimeric antigen receptor T cells)

Recruiting
  • Glioma
  • +2 more
  • chimeric antigen receptor T cells
  • Beijing, China
    Xuanwu Hospital
Jun 12, 2021

Diabetic Nephropathies Trial in Boston, Ann Arbor (Fenofibrate, Placebo)

Recruiting
  • Diabetic Nephropathies
  • Boston, Massachusetts
  • +1 more
Aug 15, 2022

Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)

Completed
  • Solid Tumors
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Breast Adenocarcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in United States (Eribulin Mesylate, Laboratory

Suspended
  • Breast Adenocarcinoma
  • +4 more
  • Eribulin Mesylate
  • +3 more
  • Scottsdale, Arizona
  • +38 more
May 25, 2022

Glioblastoma Trial in Brisbane, Heidelberg (KB004)

Completed
  • Glioblastoma
  • Brisbane, Queensland, Australia
  • +1 more
Nov 3, 2021

Colorectal Cancer Trial (Cetuximab, mFOLFOX6, FOLFIRI)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 29, 2021

Glioblastoma, Glioma Trial in New York (Bevacizumab, Peptide Vaccine, Poly-ICLC as immune adjuvant)

Withdrawn
  • Glioblastoma
  • Glioma
  • New York, New York
    NYU Perlmutter Cancer Center
Jan 8, 2020

Metastatic Melanoma Trial in Pittsburgh (DC vaccine, Dasatinib)

Completed
Has Results
  • Metastatic Melanoma
  • Pittsburgh, Pennsylvania
    Hillman Cancer Center
Aug 12, 2019

Solid Tumors, Urothelial Carcinoma, Gastric Carcinoma Trial in United States (MM-310)

Unknown status
  • Solid Tumors
  • +11 more
  • Scottsdale, Arizona
  • +4 more
Feb 26, 2018

Glioblastoma, CNS Disease, Brain Diseases Trial in Houston (Dasatinib, RT (Radiotherapy), TMZ (Temozolomide))

Terminated
  • Glioblastoma
  • +2 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 7, 2018

Melanoma (Skin) Trial in Pittsburgh (polarized dendritic cells, non-polarized dendritic cells)

Completed
  • Melanoma (Skin)
  • polarized dendritic cells
  • non-polarized dendritic cells
  • Pittsburgh, Pennsylvania
  • +1 more
Sep 25, 2017

Malignant Mesothelioma Trial in United States (dasatinib)

Completed
Has Results
  • Malignant Mesothelioma
  • La Jolla, California
  • +36 more
Jul 11, 2016

Breast Cancer Trial in Edmonton (Dasatinib)

Withdrawn
  • Breast Cancer
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 12, 2016

Myelodysplastic Syndrome (MDS), Myelofibrosis (MF) Trial in Australia, United States (KB004, Monoclonal Antibody)

Suspended
  • Myelodysplastic Syndrome (MDS)
  • Myelofibrosis (MF)
  • KB004, Monoclonal Antibody
  • Palo Alto, California
  • +8 more
Nov 13, 2015

Recurrent Skin Cancer, Squamous Cell Carcinoma of the Skin, Stage 0 Chronic Lymphocytic Leukemia Trial in Cincinnati, Columbus,

Completed
Has Results
  • Recurrent Skin Cancer
  • +3 more
  • Cincinnati, Ohio
  • +2 more
May 21, 2015

B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus

Terminated
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • alvespimycin hydrochloride
  • +3 more
  • Columbus, Ohio
    Ohio State University Medical Center
Nov 3, 2015

Cancer Trial in Bethesda, Detroit (MEDI-547)

Terminated
  • Cancer
  • Bethesda, Maryland
  • +1 more
Nov 16, 2011

Breast Cancer, Metastasis Trial in Worldwide (Dasatinib)

Completed
Has Results
  • Breast Cancer
  • Metastasis
  • San Francisco, California
  • +9 more
Feb 18, 2011